|
Q2 2025
|
42 |
1,342,486 |
MLTX, EYPT, BBIO, PRAX
|
13F-HR
|
8/14/2025 |
000158397725000007 |
|
Q1 2025
|
44 |
1,329,946 |
MLTX, EWTX, BBIO, ACLX
|
13F-HR
|
5/15/2025 |
000158397725000005 |
|
Q4 2024
|
48 |
1,820,860 |
MLTX, PRAX, JANX, ACLX
|
13F-HR
|
2/14/2025 |
000158397725000001 |
|
Q3 2024
|
45 |
1,885,759 |
MLTX, PCVX, ACLX, LBPH
|
13F-HR
|
11/14/2024 |
000158397724000006 |
|
Q2 2024
|
49 |
1,731,086 |
MLTX, CRBP, ACLX, PCVX
|
13F-HR
|
8/14/2024 |
000158397724000003 |
|
Q1 2024
|
57 |
2,279,648 |
MLTX, EYPT, ACLX, ALPN
|
13F-HR
|
5/15/2024 |
000158397724000002 |
|
Q4 2023
|
48 |
2,093,868 |
MLTX, AMAM, EYPT, BBIO
|
13F-HR
|
2/14/2024 |
000158397724000001 |
|
Q3 2023
|
49 |
1,714,347 |
MLTX, BBIO, AMAM, ACLX
|
13F-HR
|
11/14/2023 |
000158397723000005 |
|
Q2 2023
|
64 |
1,785,149 |
MLTX, AMAM, APLS, BMEA
|
13F-HR
|
8/14/2023 |
000158397723000003 |
|
Q1 2023
|
72 |
1,518,444 |
RXDX, MLTX, BMEA, APLS
|
13F-HR
|
5/15/2023 |
000158397723000002 |
|
Q4 2022
|
73 |
1,494,448 |
RXDX, APLS, ACLX, MLTX
|
13F-HR
|
2/14/2023 |
000158397723000001 |
|
Q3 2022
|
73 |
1,430,700 |
RXDX, APLS, DSGN, ERAS
|
13F-HR
|
11/14/2022 |
000158397722000007 |
|
Q2 2022
|
80 |
1,322,563 |
TPTX, DSGN, ERAS, RXDX
|
13F-HR
|
8/15/2022 |
000158397722000006 |
|
Q1 2022
|
77 |
1,302,462 |
TPTX, ERAS, DSGN, RXDX
|
13F-HR
|
5/16/2022 |
000158397722000002 |
|
Q4 2021
|
78 |
1,681,198 |
ERAS, TPTX, DSGN, RXDX
|
13F-HR
|
2/14/2022 |
000158397722000001 |
|
Q3 2021
|
88 |
2,461,043 |
ERAS, TPTX, AVIR, FORMA THERAPEUTICS HLDGS INC
|
13F-HR
|
11/15/2021 |
000158397721000009 |
|
Q2 2021
|
104 |
2,943,659 |
TPTX, IWM puts, AVIR, FORMA THERAPEUTICS HLDGS INC
|
13F-HR
|
8/16/2021 |
000158397721000008 |
|
Q1 2021
|
120 |
4,488,679 |
IWM puts, SPY puts, AVIR, TPTX
|
13F-HR
|
5/17/2021 |
000158397721000005 |
|
Q4 2020
|
105 |
4,202,158 |
TPTX, AVIR, QQQ puts, XBI puts
|
13F-HR
|
2/16/2021 |
000158397721000003 |
|
Q3 2020
|
93 |
2,600,688 |
TPTX, SPY puts, FORMA THERAPEUTICS HLDGS INC, RVMD
|
13F-HR
|
11/16/2020 |
000158397720000005 |
|
Q2 2020
|
81 |
2,620,817 |
TPTX, SPY puts, FORMA THERAPEUTICS HLDGS INC, CHEMOCENTRYX INC
|
13F-HR
|
8/14/2020 |
000158397720000004 |
|
Q1 2020
|
73 |
2,152,141 |
SPY puts, TPTX, PRNB, BBIO
|
13F-HR
|
5/15/2020 |
000158397720000003 |
|
Q4 2019
|
67 |
2,505,998 |
TPTX, RETA, MRTX, CHEMOCENTRYX INC
|
13F-HR
|
2/14/2020 |
000158397720000001 |
|
Q3 2019
|
75 |
1,642,801 |
TPTX, MRTX, SPY puts, APLS
|
13F-HR
|
11/14/2019 |
000158397719000006 |
|
Q2 2019
|
72 |
1,740,987 |
TPTX, MRTX, XBI puts, RETA
|
13F-HR
|
8/14/2019 |
000158397719000004 |
|
Q1 2019
|
64 |
1,479,543 |
IFRX, XBI puts, MRTX, ASND
|
13F-HR
|
5/15/2019 |
000158397719000003 |
|
Q4 2018
|
70 |
1,231,704 |
TSRO calls, MRTX, ANAB, TSRO
|
13F-HR
|
2/14/2019 |
000158397719000001 |
|
Q3 2018
|
65 |
1,538,535 |
ANAB, MRTX, NKTR, NKTR calls
|
13F-HR
|
11/14/2018 |
000158397718000005 |
|
Q2 2018
|
58 |
1,351,367 |
APLS, MRTX, NKTR calls, ANAB
|
13F-HR
|
8/14/2018 |
000156761918000936 |
|
Q1 2018
|
52 |
1,341,490 |
NKTR, NKTR calls, ANAB, APLS
|
13F-HR
|
5/15/2018 |
000158397718000004 |
|
Q4 2017
|
52 |
955,302 |
ANAB, NKTR, APLS, NKTR calls
|
13F-HR
|
2/14/2018 |
000158397718000002 |
|
Q3 2017
|
51 |
566,356 |
MYOK, IGNYTA INC, OMER, ANAB
|
13F-HR
|
11/14/2017 |
000158397717000005 |
|
Q2 2017
|
71 |
603,293 |
PTLA, TBPH, BLUE, QUOTIENT LTD
|
13F-HR
|
8/14/2017 |
000158397717000004 |
|
Q1 2017
|
75 |
688,685 |
TBPH, NVRO, PTI, GLPG
|
13F-HR
|
5/15/2017 |
000158397717000003 |
|
Q4 2016
|
77 |
741,848 |
PTI, TBPH, NVRO, ALDR
|
13F-HR
|
2/14/2017 |
000158397717000002 |
|
Q3 2016
|
84 |
906,836 |
ALDR, NVRO, TBPH, NERV
|
13F-HR
|
11/14/2016 |
000158397716000008 |
|
Q2 2016
|
84 |
705,177 |
ALDR, NVRO, HRTX, TSRO
|
13F-HR
|
8/15/2016 |
000114036116076682 |
|
Q1 2016
|
84 |
663,828 |
ALDR, HRTX, SAGE, OMER
|
RESTATEMENT
|
5/17/2016 |
000114036116066002 |
|
Q4 2015
|
82 |
835,862 |
ALKS, DYAX, HRTX, EGRX
|
13F-HR
|
2/16/2016 |
000114036116053224 |
|
Q3 2015
|
87 |
626,096 |
HRTX, ALKS, NBIX, DYAX
|
13F-HR
|
11/16/2015 |
000114036115041700 |
|
Q2 2015
|
80 |
752,151 |
ALKS, HRTX, RCPT, ALDR
|
13F-HR
|
8/14/2015 |
000114036115032295 |
|
Q1 2015
|
71 |
647,100 |
RCPT, ALKS, PBYI, EGRX
|
13F-HR
|
5/15/2015 |
000114036115020350 |
|
Q4 2014
|
70 |
648,511 |
RCPT, PBYI, CELG, MLND
|
13F-HR
|
2/17/2015 |
000114036115007391 |
|
Q3 2014
|
65 |
486,175 |
PBYI, RCPT, JAZZ, DYAX
|
13F-HR
|
11/14/2014 |
000114036114041889 |
|
Q2 2014
|
54 |
377,374 |
RCPT, OMER, QCOR, KPTI
|
13F-HR
|
8/14/2014 |
000114036114032474 |
|
Q1 2014
|
46 |
434,881 |
MDVN, CBST, PBYI, BMRN
|
13F-HR
|
5/15/2014 |
000114036114021247 |
|
Q4 2013
|
37 |
344,573 |
MDVN, CBST, KERX, DYAX
|
13F-HR
|
2/14/2014 |
000114036114007278 |